Search

Biomarkers reveal how patients with glaucoma may respond to treatment

Markers in the blood that predict whether glaucoma patients are at higher risk of continued loss of vision following conventional treatment have been identified by researchers at UCL and Moorfields Eye Hospital.

Glaucoma UK announces the recipients of its 2025 project grants

Glaucoma UK is delighted to announce the three recipients of our 2025 project grants. The panel had a difficult time deciding between some strong applications. The recipients are: Associate Professor Kuang Hu, at UCL Institute of Ophthalmology. His project is...

Newmedica strengthens glaucoma services with optometrist-turned-ophthalmologist appointment

Newmedica, a leading provider of ophthalmology services across England, has appointed Richard Stead as its lead for glaucoma. This strategic move underscores Newmedica's commitment to delivering exceptional and timely care for both NHS and private patients across the spectrum of...

Ciliatech presents preliminary results on treating glaucoma with CID at Ophthalmology Futures Symposium

Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.

Glaucoma UK launches the Pitts Crick Career Development Fellowship in celebration of its golden jubilee anniversary

Glaucoma UK is a leading charity dedicated to supporting those affected by glaucoma. The charity is proud to announce the establishment of the Pitts Crick Career Development Fellowship, a three-year post-doctoral research fellowship awarded to help mark the charity’s golden jubilee anniversary. The fellowship will support a rising star within glaucoma research, who the charity hopes will go on to play a pivotal role in transforming glaucoma diagnosis or treatment into the future.

Midland Eye performs its first Presserflo Microshunt to treat Glaucoma

Eye clinic, Midland Eye, announces the success of its first sight-saving Preserflo Microshunt glaucoma procedure.

Free Q3 Lunch and Learn Training Webinar: The mediSIGHT Glaucoma Pathway

In this free lunch and learn webinar we will take you through the entire Glaucoma pathway in mediSIGHT including: How to use surgeon defaults for more efficient clinics Medication defaults Visual Fields Viewer Optic disc height fields Glaucoma summaries chart...

Study shows laser treatment could significantly improve treatment for glaucoma in Africa

Results of a trial published in Lancet Global Health on 14/10/21 could pave the way for significant improvements in treatment for glaucoma in Sub-Saharan Africa.

Local campaigner with glaucoma from Manchester shortlisted for RNIB See Differently Award

A man from Manchester has been shortlisted for an RNIB See Differently Award in recognition of his campaigning to raise awareness of glaucoma and the importance of eye care among young people and those of East Asian heritage.

Know Your Risk: Glaucoma UK launches interactive online quiz to help prevent sight loss

Glaucoma is one of the leading causes of blindness in the UK – it can affect anyone, at any time, and is often symptomless. Approximately 700,000 people in the UK have glaucoma, but 50% of them don’t know - if...

New GIRFT glaucoma guidance – opportunities for improvement through primary eyecare services

Primary eyecare organisations have welcomed the publication of NHS England's Getting It Right First Time (GIRFT) Best Practice Guidance for Glaucoma Services. If implemented by ICBs as intended, the new guidance should mark an important step forward in the delivery...

Landmark review of glaucoma treatment and research published by Moorfields-led team

Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.